Clearance Summary
Enroute 0.014'' Transcarotid Guidewire received FDA 510(k) clearance under submission number K253746, sponsored by Lake Region Medical. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2026-03-19.
- Submission: K253746
- Applicant / Sponsor: Lake Region Medical
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1330
- Decision date: 2026-03-19
Classification & Regulation
This clearance is catalogued under FDA product code DQX and 21 CFR 870.1330, within the Cardiovascular review panel as a Class II device.